Review of bioactive glass: From Hench to hybrids
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hench, 1971, Bonding mechanisms at the interface of ceramic prosthetic materials, J Biomed Mater Res Symp, 334, 117, 10.1002/jbm.820050611
Kokubo, 1991, Bioactive glass-ceramics – properties and applications, Biomaterials, 12, 155, 10.1016/0142-9612(91)90194-F
LeGeros RZ. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res 2002;395;81–98.
Rahaman, 2011, Bioactive glass in tissue engineering, Acta Biomater, 7, 2355, 10.1016/j.actbio.2011.03.016
Jung, 2011, Treatment of non-healing diabetic venous stasis ulcers with bioactive glass nanofibers, Wound Repair Regen, 19, A30
Abou Neel EA, Pickup DM, Valappil SP, Newport RJ, Knowles JC. Bioactive functional materials: a perspective on phosphate-based glasses. J Mater Chem 2009;19:690–701.
Kucera, 2012, Healing of cavitary bone defects, Eur J Orthop Surg Traumatol, 22, 123, 10.1007/s00590-011-0831-9
Moutos, 2007, A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage, Nat Mater, 6, 162, 10.1038/nmat1822
Hench, 2011, Bioactive materials for gene control, 25
Rust, 1996, Bioglass middle ear prosthesis: long-term results, Am J Otolaryngol, 17, 371
Stanley, 1997, Using 45S5 bioglass cones as endosseous ridge maintenance implants to prevent alveolar ridge resorption: a 5-year evaluation, Int J Oral Maxillofac Implants, 12, 95
Thompson, 2011, Clinical applications of bioactive glasses for maxillofacial repair, 77
Kinnunen, 2000, Reconstruction of orbital floor fractures using bioactive glass, J Craniofac-Maxillofac Surg, 28, 229, 10.1054/jcms.2000.0140
Fetner, 1987, Histologic evaluation of bioglass particulates in gingival tissue, J Dent Res, 66, 298
Wilson, 1992, Bioactive ceramics for periodontal treatment – comparative studies in the Patus monkey, J Appl Biomater, 3, 123, 10.1002/jab.770030208
Schepers, 1997, Bioactive glass particles of narrow size range for the treatment of oral bone defects: a 1–24months experiment with several materials and particle sizes and size ranges, J Oral Rehabil, 24, 171, 10.1111/j.1365-2842.1997.tb00311.x
Low SB, King CJ, Krieger J. An evaluation of bioactive ceramic in the treatment of periodontal osseous defects. Int J Periodontol Rest, Dent 1997;17:359–67.
Lovelace, 1998, Clinical evaluation of bioactive glass in the treatment of periodontal osseous defects in humans, J Periodontol, 69, 1027, 10.1902/jop.1998.69.9.1027
Rosenberg, 2004, A comparison of characteristics of implant failure and survival in periodontally compromised and periodontally healthy patients: a clinical report, Int J Oral Maxillofac Implants, 19, 873
Anderegg, 1999, A bioactive glass particulate in the treatment of molar furcation invasions, J Periodontol, 70, 384, 10.1902/jop.1999.70.4.384
Yukna, 2001, Clinical comparison of bioactive glass bone replacement graft material and expanded polytetrafluoroethylene barrier membrane in treating human mandibular molar Class II furcations, J Periodontol, 72, 125, 10.1902/jop.2001.72.2.125
Park JS, Suh JJ, Choi SH, Moon IS, Cho KS, Kim CK, et al. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects. J Periodontol 2001;72:730–40.
Norton, 2002, Dental implants placed in extraction sites implanted with bioactive glass: human histology and clinical outcome, Int J Oral Maxillofac Implants, 17, 249
Sculean, 2002, Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans, J Periodontol, 73, 401, 10.1902/jop.2002.73.4.401
Mengel, 2003, Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study, J Periodontol, 74, 899, 10.1902/jop.2003.74.6.899
Froum, 1998, Comparison of bioactive glass synthetic bone graft particles and open debridement in the treatment of human periodontal defects. A clinical study, J Periodontol, 69, 698, 10.1902/jop.1998.69.6.698
Shapoff CA, Alexander DC, Clark AE. Clinical use of a bioactive glass particulate in the treatment of human osseous defects. Compend Contin Educ Dent (Jamesburg, NJ: 1995) 1997;18:352–58.
Zamet, 1997, Particulate Bioglass® as a grafting material in the treatment of periodontal intrabony defects, J Clin Periodontol, 24, 410, 10.1111/j.1600-051X.1997.tb00205.x
Zamet, 1997, Particulate bioglass (Perioglas®) in the treatment of periodontal intrabony defects, J Dent Res, 76, 2219
AboElsaad, 2009, Effect of soft laser and bioactive glass on bone regeneration in the treatment of infra-bony defects (a clinical study), Lasers Med Sci, 24, 387, 10.1007/s10103-008-0576-9
Yadav, 2011, Clinical evaluation of guided tissue regeneration combined with autogenous bone or autogenous bone mixed with bioactive glass in intrabony defects, J Oral Sci, 53, 481, 10.2334/josnusd.53.481
Waltimo T, Mohn D, Paque F, Brunner TJ, Stark WJ, Imfeld T, et al. Fine-tuning of bioactive glass for root canal disinfection. J Dent Res 2009;88:235–38.
Ilharreborde, 2008, Bioactive glass as a bone substitute for spinal fusion in adolescent idiopathic scoliosis a comparative study with iliac crest autograft, J Pediatr Orthop, 28, 347, 10.1097/BPO.0b013e318168d1d4
Turunen, 2004, Bioactive glass granules as a bone adjunctive material in maxillary sinus floor augmentation, Clin Oral Implants Res, 15, 135, 10.1111/j.1600-0501.2004.00989.x
Peltola, 2006, Bioactive glass S53P4 in frontal sinus obliteration: a long-term clinical experience, Head Neck, 28, 834, 10.1002/hed.20436
Frantzen, 2011, Instrumented spondylodesis in degenerative spondylolisthesis with bioactive glass and autologous bone: a prospective 11-year follow-up, J Spinal Disord Tech, 24, 455, 10.1097/BSD.0b013e31822a20c6
Lindfors, 2010, Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis, Bone, 47, 212, 10.1016/j.bone.2010.05.030
Rantakokko, 2012, Posterolateral spondylodesis using bioactive glass S53P4 and autogenous bone in instrumented unstable lumbar spine burst fractures, Scand J Surg, 101, 66, 10.1177/145749691210100113
Pernaa, 2011, Bioactive glass S53P4 and autograft bone in treatment of depressed tibial plateau fractures – a prospective randomized 11-year follow-up, J Long-term Eff Med Implants, 21, 139, 10.1615/JLongTermEffMedImplants.v21.i2.40
Heikkila, 2011, Bioactive glass granules: a suitable bone substitute material in the operative treatment of depressed lateral tibial plateau fractures: a prospective, randomized 1 year follow-up study, J Mater Sci – Mater Med, 22, 1073, 10.1007/s10856-011-4272-0
Lindfors, 2010, A prospective randomized 14-year follow-up study of bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors, J Biomed Mater Res Part B, 94B, 157, 10.1002/jbm.b.31636
Lindfors, 2009, Bioactive glass and autogenous bone as bone graft substitutes in benign bone tumors, J Biomed Mater Res Part B, 90B, 131, 10.1002/jbm.b.31263
Lindfors, 2008, Long-term evaluation of blood silicon and ostecalcin in operatively treated patients with benign bone tumors using bioactive glass and autogenous bone, J Biomed Mater Res Part B, 87B, 73, 10.1002/jbm.b.31070
Stoor P, Pulkkinen J, Grenman R. Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media. Ann Otolaryngol Rhinol Laryngol 2010;119:377–82.
Gillam DG, Tang JY, Mordan NJ, Newman HN. The effects of a novel Bioglass® dentifrice on dentine sensitivity: a scanning electron microscopy investigation. J Oral Rehabil 2002;29:305–13.
Tai, 2006, Anti-gingivitis effect of a dentifrice containing bioactive glass (NovaMin®) particulate, J Clin Periodontol, 33, 86, 10.1111/j.1600-051X.2005.00876.x
Pradeep, 2010, Comparison of clinical efficacy of a dentifrice containing calcium sodium phosphosilicate to a dentifrice containing potassium nitrate and to a placebo on dentinal hypersensitivity: a randomized clinical trial, J Periodontol, 81, 1167, 10.1902/jop.2010.100056
Earl, 2011, Physical and chemical characterization of dentin surface, following treatment with NovaMin® technology, J Clin Dent, 22, 2
Mitchell, 2011, Biomimetic dentin desensitizer based on nano-structured bioactive glass, Dent Mater, 27, 386, 10.1016/j.dental.2010.11.019
Mneimne, 2011, High phosphate content significantly increases apatite formation of fluoride-containing bioactive glasses, Acta Biomater, 7, 1827, 10.1016/j.actbio.2010.11.037
Lusvardi, 2009, Fluoride-containing bioactive glasses: surface reactivity in simulated body fluids solutions, Acta Biomater, 5, 3548, 10.1016/j.actbio.2009.06.009
Brauer, 2011, Fluoride-containing bioactive glasses: fluoride loss during melting and ion release in tris buffer solution, J Non-Cryst Solids, 357, 3328, 10.1016/j.jnoncrysol.2011.05.031
Banerjee, 2010, A clinical evaluation and comparison of bioactive glass and sodium bicarbonate air-polishing powders, J Dentistry, 38, 475, 10.1016/j.jdent.2010.03.001
Gomez-Vega, 2000, Novel bioactive functionally graded coatings on Ti6Al4V, Adv Mater, 12, 894, 10.1002/1521-4095(200006)12:12<894::AID-ADMA894>3.0.CO;2-4
Gomez-Vega, 2001, Bioactive glass-mesoporous silica coatings on Ti6Al4V through enameling and triblock-copolymer-templated sol–gel processing, J Biomed Mater Res, 56, 382, 10.1002/1097-4636(20010905)56:3<382::AID-JBM1107>3.0.CO;2-P
Gomez-Vega, 1999, Glass-based coatings for titanium implant alloys, J Biomed Mater Res, 46, 549, 10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M
Gomez-Vega, 2000, Bioactive glass coatings with hydroxyapatite and Bioglass® particles on Ti-based implants. 1. Processing, Biomaterials, 21, 105, 10.1016/S0142-9612(99)00131-3
Lopez-Esteban, 2003, Bioactive glass coatings for orthopedic metallic implants, J Eur Ceram Soc, 23, 2921, 10.1016/S0955-2219(03)00303-0
Pavon, 2006, Delamination under Hertzian cyclic loading of a glass coating on Ti6Al4V for implants, J Mater Sci, 41, 5134, 10.1007/s10853-006-0439-3
Pazo, 1998, Silicate glass coatings on Ti-based implants, Acta Mater, 46, 2551, 10.1016/S1359-6454(98)80039-6
Moritz, 2004, Implants coated with bioactive glass by CO2-laser, an in vivo study, J Mater Sci – Mater Med, 15, 795, 10.1023/B:JMSM.0000032820.50983.c1
Mistry, 2011, Comparison of bioactive glass coated and hydroxyapatite coated titanium dental implants in the human jaw bone, Aust Dent J, 56, 68, 10.1111/j.1834-7819.2010.01305.x
Li, 1991, An investigation of bioactive glass powders by sol–gel processing, J Appl Biomater, 2, 231, 10.1002/jab.770020403
Saravanapavan, 2003, Bioactivity of gel-glass powders in the CaO-SiO2 system: a comparison with ternary (CaO–P2O5–SiO2) and quaternary glasses (SiO2–CaO–P2O5–Na2O), J Biomed Mater Res Part A, 66A, 110, 10.1002/jbm.a.10532
Brinker, 1990
Sepulveda, 2001, Characterization of melt-derived 45S5 and sol–gel-derived 58S bioactive glasses, J Biomed Mater Res, 58, 734, 10.1002/jbm.10026
Lei, 2010, Surface nanoscale patterning of bioactive glass to support cellular growth and differentiation, J Biomed Mater Res Part A, 94A, 1091, 10.1002/jbm.a.32776
Siqueira, 2011, Gel-derived SiO2–CaO–Na2O–P2O5 bioactive powders: synthesis and in vitro bioactivity, Mater Sci Eng, C, 31, 983, 10.1016/j.msec.2011.02.018
Stöber, 1968, Controlled growth of monodisperse silica spheres in micron size range, J Colloid Interf Sci, 26, 62, 10.1016/0021-9797(68)90272-5
Labbaf, 2011, Spherical bioactive glass particles and their interaction with human mesenchymal stem cells in vitro, Biomaterials, 32, 1010, 10.1016/j.biomaterials.2010.08.082
Lin, 2009, Nanostructure evolution and calcium distribution in sol–gel derived bioactive glass, J Mater Chem, 19, 1276, 10.1039/b814292k
Valliant, 2012, Role of pH and temperature on silica network formation and calcium incorporation into sol–gel derived bioactive glasses, J Mater Chem, 22, 1613, 10.1039/C1JM13225C
Saravanapavan, 2003, Mesoporous calcium silicate glasses. II. Textural characterisation, J Non-Cryst Solids, 318, 14, 10.1016/S0022-3093(02)01882-3
Brinker, 1999, Evaporation-induced self-assembly: nanostructures made easy, Adv Mater, 11, 579, 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R
Vallet-Regi, 2012, Structure and functionalization of mesoporous bioceramics for bone tissue regeneration and local drug delivery, Philos Trans R Soc A, 370, 1400, 10.1098/rsta.2011.0258
Hench, 1977, Analysis of Bioglass fixation of hip prostheses, J Biomed Mater Res, 11, 267, 10.1002/jbm.820110211
Oonishi, 2000, Quantitative comparison of bone growth behavior in granules of Bioglass®, A-W glass-ceramic, and hydroxyapatite, J Biomed Mater Res, 51, 37, 10.1002/(SICI)1097-4636(200007)51:1<37::AID-JBM6>3.0.CO;2-T
Oonishi H, Kushitani S, Yasukawa E, Iwaki H, Hench LL, Wilson J, et al. Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin Orthop Relat Res 1997;316–25.
Oonishi, 1999, Comparative bone growth behavior in granules of bioceramic materials of various sizes, J Biomed Mater Res, 44, 31, 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9
Wheeler, 2000, Assessment of resorbable bioactive material for grafting of critical-size cancellous defects, J Orthop Res, 18, 140, 10.1002/jor.1100180120
Quintero, 2009, Laser spinning of bioactive glass nanofibers, Adv Funct Mater, 19, 3084, 10.1002/adfm.200801922
Wheeler, 1998, Effect of bioactive glass particle size on osseous regeneration of cancellous defects, J Biomed Mater Res, 41, 527, 10.1002/(SICI)1097-4636(19980915)41:4<527::AID-JBM3>3.0.CO;2-E
Wang, 2011, Evaluation of an osteostimulative putty in the sheep spine, J Mater Sci – Mater Med, 22, 185, 10.1007/s10856-010-4175-5
Kobayashi, 2010, Evaluation of a silica-containing bone graft substitute in a vertebral defect model, J Biomed Mater Res Part A, 92A, 596, 10.1002/jbm.a.32397
Fujibayashi, 2003, A comparative study between in vivo bone ingrowth and in vitro apatite formation on Na2O-CaO-SiO2 glasses, Biomaterials, 24, 1349, 10.1016/S0142-9612(02)00511-2
Vogel, 2001, In vivo comparison of bioactive glass particles in rabbits, Biomaterials, 22, 357, 10.1016/S0142-9612(00)00191-5
Vogel, 2004, Development of multinuclear giant cells during the degradation of Bioglass® particles in rabbits, J Biomed Mater Res Part A, 70A, 370, 10.1002/jbm.a.30048
Hupa, 2010, Comparison of bioactive glasses in vitro and in vivo, Glass Technol – Eur J Glass Sci Technol Part A, 51, 89
Lai, 2002, Silicon excretion from bioactive glass implanted in rabbit bone, Biomaterials, 23, 213, 10.1016/S0142-9612(01)00097-7
Lai, 2005, Excretion of resorption products from bioactive glass implanted in rabbit muscle, J Biomed Mater Res Part A, 75A, 398, 10.1002/jbm.a.30425
Li, 2012, Enhancement of the osseointegration of a polyethylene terephthalate artificial ligament graft in a bone tunnel using 58S bioglass, Int Orthop, 36, 191, 10.1007/s00264-011-1275-x
Conejero, 2007, Cranial defect reconstruction in an experimental model using different mixtures of bioglass and autologous bone, J Craniofac Surg, 18, 1290, 10.1097/scs.0b013e3180f610c7
Hench, 1973, Direct chemical bonding of bioactive glass-ceramic materials and bone, J Biomed Mater Res Symp, 4, 25, 10.1002/jbm.820070304
Sanders, 1973, Mechanisms of glass corrosion, J Am Ceram Soc, 56, 373, 10.1111/j.1151-2916.1973.tb12689.x
Clark, 1976, Auger spectroscopic analysis of Bioglass corrosion films, J Am Ceram Soc, 59, 37, 10.1111/j.1151-2916.1976.tb09382.x
Hench, 1991, Bioceramics – from concept to clinic, J Am Ceram Soc, 74, 1487, 10.1111/j.1151-2916.1991.tb07132.x
Skipper, 2005, The structure of a bioactive calcia-silica sol–gel glass, J Mater Chem, 15, 2369, 10.1039/b501496d
Martin, 2009, A study of the formation of amorphous calcium phosphate and hydroxyapatite on melt quenched Bioglass® using surface sensitive shallow angle X-ray diffraction, J Mater Sci – Mater Med, 20, 883, 10.1007/s10856-008-3661-5
Li, 1990, The electrochemistry of a glass-surface and its application to bioactive glass in solution, J Non-Cryst Solids, 119, 112, 10.1016/0022-3093(90)90247-J
Doostmohammadi, 2011, A comparative physico-chemical study of bioactive glass and bone-derived hydroxyapatite, Ceram Int, 37, 1601, 10.1016/j.ceramint.2011.03.009
Karlsson, 1989, A structural approach to bone adhering of bioactive glasses, J Non-Cryst Solids, 112, 69, 10.1016/0022-3093(89)90495-X
FitzGerald, 2009, An atomic scale comparison of the reaction of Bioglass® in two types of simulated body fluid, Phys Chem Glasses – Eur J Glass Sci Technol Part B, 50, 137
FitzGerald, 2009, Bioactive glass sol–gel foam scaffolds: evolution of nanoporosity during processing and in situ monitoring of apatite layer formation using small- and wide-angle X-ray scattering, J Biomed Mater Res Part A, 91A, 76, 10.1002/jbm.a.32206
Arcos, 2003, A new quantitative method to evaluate the in vitro bioactivity of melt and sol–gel-derived silicate glasses, J Biomed Mater Res Part A, 65A, 344, 10.1002/jbm.a.10503
Greenspan, 1976, Chemical and mechanical behavior of Bioglass-coated alumina, J Biomed Mater Res, 10, 503, 10.1002/jbm.820100405
Gross, 1980, The anchoring of glass-ceramics of different solubility in the femur of the rat, J Biomed Mater Res, 14, 607, 10.1002/jbm.820140507
Vallet-Regi M, Ragel CV, Salinas AJ. Glasses with medical applications. Eur J, Inorg Chem 2003;1029–42.
Hench, 2010, Twenty-first century challenges for biomaterials, J R Soc Interf, 7, S379, 10.1098/rsif.2010.0151.focus
Gough, 2004, Nodule formation and mineralisation of human primary osteoblasts cultured on a porous bioactive glass scaffold, Biomaterials, 25, 2039, 10.1016/j.biomaterials.2003.07.001
Kaufmann, 2000, Evaluation of osteoblast response to porous bioactive glass (45S5) substrates by RT-PCR analysis, Tissue Eng, 6, 19, 10.1089/107632700320856
Bosetti, 2005, The effect of bioactive glasses on bone marrow stromal cells differentiation, Biomaterials, 26, 3873, 10.1016/j.biomaterials.2004.09.059
Jones, 2007, Extracellular matrix formation and mineralization of on a phosphate-free porous bioactive glass scaffold using primary human osteoblast (HOB) cells, Biomaterials, 28, 1653, 10.1016/j.biomaterials.2006.11.022
Silver, 2001, Interactions of bioactive glasses with osteoblasts in vitro: effects of 45S5 Bioglass®, and 58S and 77S bioactive glasses on metabolism, intracellular ion concentrations and cell viability, Biomaterials, 22, 175, 10.1016/S0142-9612(00)00173-3
Xynos, 2001, Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass® 45S5 dissolution, J Biomed Mater Res, 55, 151, 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.0.CO;2-D
Xynos, 2000, Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis, Biochem Biophys Res Commun, 276, 461, 10.1006/bbrc.2000.3503
Xynos, 2000, Bioglass® 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering, Calcified Tissue Int, 6, 321, 10.1007/s002230001134
Hench, 2009, Genetic design of bioactive glass, J Eur Ceram Soc, 29, 1257, 10.1016/j.jeurceramsoc.2008.08.002
Hench, 2000, Bioactive materials to control cell cycle, Mater Res Innovations, 3, 313, 10.1007/s100190000055
Marie, 2010, The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis, Bone, 46, 571, 10.1016/j.bone.2009.07.082
Maeno, 2005, The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture, Biomaterials, 26, 4847, 10.1016/j.biomaterials.2005.01.006
Valerio, 2009, Effects of extracellular calcium concentration on the glutamate release by bioactive glass (BG60S) preincubated osteoblasts, Biomed Mater, 4, 045011, 10.1088/1748-6041/4/4/045011
Reffitt, 2003, Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro, Bone, 32, 127, 10.1016/S8756-3282(02)00950-X
Hoppe, 2011, A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics, Biomaterials, 32, 2757, 10.1016/j.biomaterials.2011.01.004
Jell, 2008, Bioactive glass-induced osteoblast differentiation: a noninvasive spectroscopic study, J Biomed Mater Res Part A, 86A, 31, 10.1002/jbm.a.31542
Tsigkou, 2009, Differentiation of fetal osteoblasts and formation of mineralized bone nodules by 45S5 Bioglass® conditioned medium in the absence of osteogenic supplements, Biomaterials, 30, 3542, 10.1016/j.biomaterials.2009.03.019
Reilly, 2007, Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass, Biomaterials, 28, 4091, 10.1016/j.biomaterials.2007.05.038
Karpov, 2008, Sol–gel bioactive glasses support both osteoblast and osteoclast formation from human bone marrow cells, J Biomed Mater Res Part A, 84A, 718, 10.1002/jbm.a.31386
Bielby, 2005, Enhanced derivation of osteogenic cells from murine embryonic stem cells after treatment with ionic dissolution products of 58S bioactive sol–gel glass, Tissue Eng, 11, 479, 10.1089/ten.2005.11.479
Haimi, 2009, Calcium phosphate surface treatment of bioactive glass causes a delay in early osteogenic differentiation of adipose stem cells, J Biomed Mater Res Part A, 91A, 540, 10.1002/jbm.a.32233
Wilson, 2006, Intact surface of bioactive glass S53P4 is resistant to osteoclastic activity, J Biomed Mater Res Part A, 77A, 67, 10.1002/jbm.a.30600
Hamadouche, 2001, Long-term in vivo bioactivity and degradability of bulk sol–gel bioactive glasses, J Biomed Mater Res, 54, 560, 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.0.CO;2-J
Martin, 2012, Characterizing the hierarchical structures of bioactive sol–gel silicate glass and hybrid scaffolds for bone regeneration, Philos Trans R Soc A, 370, 1422, 10.1098/rsta.2011.0308
Cormack, 2012, The structure of bioactive glasses and their surfaces, 65
FitzGerald, 2007, A neutron and X-ray diffraction study of bioglass with reverse Monte Carlo modelling, Adv Funct Mater, 17, 3746, 10.1002/adfm.200700433
Elgayar, 2005, Structural analysis of bioactive glasses, J Non-Cryst Solids, 351, 173, 10.1016/j.jnoncrysol.2004.07.067
Pedone, 2010, New insights into the atomic structure of 45S5 bioglass by means of solid-state NMR spectroscopy and accurate first-principles simulations, Chem Mater, 22, 5644, 10.1021/cm102089c
Cerruti, 2005, Surface modifications of bioglass immersed in TRIS-buffered solution. A multitechnical spectroscopic study, J Phys Chem B, 109, 14496, 10.1021/jp050705t
Sepulveda, 2002, In vitro dissolution of melt-derived 45S5 and sol–gel derived 58S bioactive glasses, J Biomed Mater Res, 61, 301, 10.1002/jbm.10207
Galliano, 1994, Analysis by nuclear-magnetic-resonance and Raman spectroscopies of the structure of bioactive alkaline-earth silicophosphate glasses, J Mater Res Bull, 24, 1297, 10.1016/0025-5408(94)90154-6
Hill, 2011, Predicting the bioactivity of glasses using the network connectivity or split network models, J Non-Cryst Solids, 357, 3884, 10.1016/j.jnoncrysol.2011.07.025
Li, 2011, Insights into new calcium phosphosilicate xerogels using an advanced characterization methodology, J Non-Cryst Solids, 357, 3548, 10.1016/j.jnoncrysol.2011.07.003
Tilocca, 2007, The structure of bioactive silicate glasses: new insight from molecular dynamics simulations, Chem Mater, 19, 95, 10.1021/cm061631g
Mercier, 2011, Influence of P2O5 content on the structure of SiO2–Na2O–CaO–P2O5 bioglasses by 29Si and 31P MAS-NMR, J Non-Cryst Solids, 357, 3901, 10.1016/j.jnoncrysol.2011.07.042
Hill, 1996, An alternative view of the degradation of bioglass, J Mater Sci Lett, 15, 1122, 10.1007/BF00539955
O’Donnell MD, Candarlioglu PL, Miller CA, Gentleman E, Stevens MM. Materials characterisation and cytotoxic assessment of strontium-substituted bioactive glasses for bone regeneration. J Mater Chem 2010;20:8934–41.
Eden M. The split network analysis for exploring composition–structure correlations in multi-component glasses: I. Rationalizing bioactivity–composition trends of bioglasses. J Non-Cryst Solids 2011;357:1595–602.
Ottermann, 1992, Correlation of hydrogen content with properties of oxidic thin-films, Surf Interf Anal, 19, 435, 10.1002/sia.740190181
Pereira, 1995, Effect of texture on the rate of hydroxyapatite formation on gel-silica surface, J Am Ceram Soc, 78, 2463, 10.1111/j.1151-2916.1995.tb08686.x
Jones, 2003, Effect of surfactant concentration and composition on the structure and properties of sol–gel-derived bioactive glass foam scaffolds for tissue engineering, J Mater Sci, 38, 3783, 10.1023/A:1025988301542
Soulie, 2009, Influence of Mg doping on the early steps of physico-chemical reactivity of sol–gel derived bioactive glasses in biological medium, Phys Chem Chem Phys, 11, 10473, 10.1039/b913771h
Ma, 2011, Synthesis, characterization and in vitro bioactivity of magnesium-doped sol–gel glass and glass-ceramics, Ceram Int, 37, 1637, 10.1016/j.ceramint.2011.01.043
Ma, 2010, Effect of magnesia on the degradability and bioactivity of sol–gel derived SiO2–CaO–MgO–P2O5 system glasses, Colloids Surf B – Biointerfaces, 81, 87, 10.1016/j.colsurfb.2010.06.022
Mead, 2006, Modeling the local atomic structure of bioactive sol–gel-derived calcium silicates, Chem Mater, 18, 3956, 10.1021/cm0527975
Chen, 2006, 45S5 Bioglass®-derived glass-ceramic scaffolds for bone tissue engineering, Biomaterials, 27, 2414, 10.1016/j.biomaterials.2005.11.025
Bellucci, 2011, Macroporous Bioglass®-derived scaffolds for bone tissue regeneration, Ceram Int, 37, 1575, 10.1016/j.ceramint.2011.01.023
Deb, 2010, A porous scaffold for bone tissue engineering/45S5 Bioglass® derived porous scaffolds for co-culturing osteoblasts and endothelial cells, J Mater Sci – Mater Med, 21, 893, 10.1007/s10856-009-3936-5
Chen, 2011, Optimization of Bioglass® scaffold fabrication process, J Am Ceram Soc, 94, 4184, 10.1111/j.1551-2916.2011.04766.x
Peitl, 1996, Effect of crystallization on apatite-layer formation of bioactive glass 45S5, J Biomed Mater Res, 30, 509, 10.1002/(SICI)1097-4636(199604)30:4<509::AID-JBM9>3.0.CO;2-T
Massera, 2012, Crystallization mechanism of the bioactive glasses, 45S5 and S53P4, J Am Ceram Soc, 95, 607, 10.1111/j.1551-2916.2011.05012.x
Brink, 1997, The influence of alkali and alkaline earths on the working range for bioactive glasses, J Biomed Mater Res, 36, 109, 10.1002/(SICI)1097-4636(199707)36:1<109::AID-JBM13>3.0.CO;2-D
Brink, 1997, Compositional dependence of bioactivity of glasses in the system Na2O–K2O–MgO–CaO–B2O3–P2O5–SiO2, J Biomed Mater Res, 37, 114, 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G
Vedel E, Zhang D, Arstila H, Hupa L, Hupa M. Predicting physical and chemical properties of bioactive glasses from chemical composition. Part 4: Tailoring compositions with desired properties. Glass Technol – Eur J Glass Sci Technol Part A 2009;50:9–16.
Oudadesse H, Dietrich E, Gal YL, Pellen P, Bureau B, Mostafa AA, et al. Apatite forming ability and cytocompatibility of pure and Zn-doped bioactive glasses. Biomed Mater 2011;6. http://dx.doi.org/10.1088/1748-6041/6/3/035006.
Watts, 2010, Influence of magnesia on the structure and properties of bioactive glasses, J Non-Cryst Solids, 356, 517, 10.1016/j.jnoncrysol.2009.04.074
Moimas, 2006, Rabbit pilot study on the resorbability of three-dimensional bioactive glass fibre scaffolds, Acta Biomater, 2, 191, 10.1016/j.actbio.2005.09.006
Bellucci, 2011, A new potassium-based bioactive glass: sintering behaviour and possible applications for bioceramic scaffolds, Ceram Int, 37, 145, 10.1016/j.ceramint.2010.08.020
Cannillo, 2009, Potassium-based composition for a bioactive glass, Ceram Int, 35, 3389, 10.1016/j.ceramint.2009.06.011
Bellucci, 2011, Calcium and potassium addition to facilitate the sintering of bioactive glasses, Mater Lett, 65, 1825, 10.1016/j.matlet.2011.03.060
Wallace, 1999, Influence of sodium oxide content on bioactive glass properties, J Mater Sci – Mater Med, 10, 697, 10.1023/A:1008910718446
Jayabalan, 2011, Bioactive glass 13–93 as a subchondral substrate for tissue-engineered osteochondral constructs: a pilot study, Clin Orthop Relat Res, 469, 2754, 10.1007/s11999-011-1818-x
Deville, 2006, Freezing as a path to build complex composites, Science, 311, 515, 10.1126/science.1120937
Fu Q, Rahaman MN, Bal BS, Bonewald LF, Kuroki K, Brown RF. Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological evaluation. J Biomed Mater Res Part A 2010;95A:172–79.
Fu Q, Rahaman MN, Bal BS, Kuroki K, Brown RF. In vivo evaluation of 13–93 bioactive glass scaffolds with trabecular and oriented microstructures in a subcutaneous rat implantation model. J Biomed Mater Res Part A 2010;95A:235–44.
Liu, 2012, Porous and strong bioactive glass (13–93) scaffolds prepared by unidirectional freezing of camphene-based suspensions, Acta Biomater, 8, 415, 10.1016/j.actbio.2011.07.034
Liu, 2011, Oriented bioactive glass (13–93) scaffolds with controllable pore size by unidirectional freezing of camphene-based suspensions: microstructure and mechanical response, Acta Biomater, 7, 406, 10.1016/j.actbio.2010.08.025
Wu, 2011, Melt-derived bioactive glass scaffolds produced by a gel-cast foaming technique, Acta Biomater, 7, 1807, 10.1016/j.actbio.2010.11.041
Sepulveda, 2002, Bioactive sol–gel foams for tissue repair, J Biomed Mater Res, 59, 340, 10.1002/jbm.1250
Jones, 2007, Non-destructive quantitative 3D analysis for the optimisation of tissue scaffolds, Biomaterials, 28, 1404, 10.1016/j.biomaterials.2006.11.014
Jones, 2010, Bioactive glass scaffolds for bone regeneration and their hierarchical characterisation, Proc Inst Mech Eng H – J Eng Med, 224, 1373, 10.1243/09544119JEIM836
Jones, 2004, Factors affecting the structure and properties of bioactive foam scaffolds for tissue engineering, J Biomed Mater Res Part B, 68B, 36, 10.1002/jbm.b.10071
Coelho, 2005, Sol–gel synthesis of bioactive glass scaffolds for tissue engineering: effect of surfactant type and concentration, J Biomed Mater Res Part B, 75B, 451, 10.1002/jbm.b.30354
Jones, 2006, Optimising bioactive glass scaffolds for bone tissue engineering, Biomaterials, 27, 964, 10.1016/j.biomaterials.2005.07.017
Wang, 2011, Evaluation of 3D nano-macro porous bioactive glass scaffold for hard tissue engineering, J Mater Sci – Mater Med, 22, 1195, 10.1007/s10856-011-4297-4
Almeida, 2011, Bioactive sol–gel scaffolds with dual porosity for tissue engineering, J Sol–Gel Sci Technol, 57, 336, 10.1007/s10971-009-2134-8
Marques, 2009, Sol–gel-derived glass scaffold with high pore interconnectivity and enhanced bioactivity, J Mater Res, 24, 3495, 10.1557/jmr.2009.0440
Valerio, 2005, Primary osteoblast cell response to sol–gel derived bioactive glass foams, J Mater Sci – Mater Med, 16, 851, 10.1007/s10856-005-3582-5
Chen, 2011, Fabrication and characterization of sol–gel derived 45S5 Bioglass®-ceramic scaffolds, Acta Biomater, 7, 3616, 10.1016/j.actbio.2011.06.005
Jallot, 2010, Imaging physicochemical reactions occurring at the pore surface in binary bioactive glass foams by micro ion beam analysis, ACS Appl Mater Interf, 2, 1737, 10.1021/am1002316
Yue, 2010, Synchrotron X-ray microtomography for assessment of bone tissue scaffolds, J Mater Sci – Mater Med, 21, 847, 10.1007/s10856-009-3888-9
Wang, 2010, High surface area nanomacroporous bioactive glass scaffold for hard tissue engineering, J Am Ceram Soc, 93, 3002, 10.1111/j.1551-2916.2010.03970.x
Wang, 2011, Synthesis and characterization of hierarchically macroporous and mesoporous CaO–MO–SiO2–P2O5 (M=Mg, Zn, Sr) bioactive glass scaffolds, Acta Biomater, 7, 3638, 10.1016/j.actbio.2011.06.029
Minaberry, 2011, Macroporous bioglass scaffolds prepared by coupling sol–gel with freeze drying, Chem Mater, 23, 2327, 10.1021/cm103362c
Jones, 2004, Large-scale production of 3D bioactive glass macroporous scaffolds for tissue engineering, J Sol–Gel Sci Technol, 29, 179, 10.1023/B:JSST.0000023848.96123.8e
Fu, 2011, Bioactive glass scaffolds for bone tissue engineering: state of the art and future perspectives, Mater Sci Eng, C, 31, 1245, 10.1016/j.msec.2011.04.022
Fu, 2011, Bioinspired strong and highly porous glass scaffolds, Adv Funct Mater, 21, 1058, 10.1002/adfm.201002030
Fu, 2011, Direct ink writing of highly porous and strong glass scaffolds for load-bearing bone defects repair and regeneration, Acta Biomater, 7, 3547, 10.1016/j.actbio.2011.06.030
Doiphode, 2011, Freeze extrusion fabrication of 13–93 bioactive glass scaffolds for bone repair, J Mater Sci – Mater Med, 22, 515, 10.1007/s10856-011-4236-4
Huang, 2011, Porous and strong bioactive glass (13–93) scaffolds fabricated by freeze extrusion technique, Mater Sci Eng, C, 31, 1482, 10.1016/j.msec.2011.06.004
Kolan, 2011, Fabrication of 13–93 bioactive glass scaffolds for bone tissue engineering using indirect selective laser sintering, Biofabrication, 3, 025004, 10.1088/1758-5082/3/2/025004
Wu C, Luo Y, Cuniberti G, Xiao Y, Gelinsky M. Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability. Acta Biomater 2011;7:2644–50.
Yun HS, Kim SE, Hyeon YT. Design and preparation of bioactive glasses with hierarchical pore networks. Chem Commun 2007;2139–41.
Garcia A, Izquierdo-Barba I, Colilla M, de Laorden CL, Vallet-Regi M. Preparation of 3-D scaffolds in the SiO2–P2O5 system with tailored hierarchical meso-macroporosity. Acta Biomater 2011;7:1265–73.
Rezwan, 2006, Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering, Biomaterials, 27, 3413, 10.1016/j.biomaterials.2006.01.039
Lu, 2003, Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro, J Biomed Mater Res Part A, 64A, 465, 10.1002/jbm.a.10399
Niemela, 2005, Self-reinforced composites of bioabsorbable polymer and bioactive glass with different bloactive glass contents. Part 1: Initial mechanical properties and bioactivity, Acta Biomater, 1, 235, 10.1016/j.actbio.2004.11.002
Maquet, 2004, Porous poly(alpha-hydroxyacid)/Bioglass® composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation, Biomaterials, 25, 4185, 10.1016/j.biomaterials.2003.10.082
Blaker, 2005, Mechanical properties of highly porous PDLLA/Bioglass® composite foams as scaffolds for bone tissue engineering, Acta Biomater, 1, 643, 10.1016/j.actbio.2005.07.003
Peter, 2010, Novel biodegradable chitosan-gelatin/nano-bioactive glass ceramic composite scaffolds for alveolar bone tissue engineering, Chem Eng J, 158, 353, 10.1016/j.cej.2010.02.003
Xu, 2011, Biocompatibility and osteogenesis of biomimetic Bioglass-collagen-phosphatidylserine composite scaffolds for bone tissue engineering, Biomaterials, 32, 1051, 10.1016/j.biomaterials.2010.09.068
Chen, 2006, Poly(d,l-lactic acid) coated 45S5 Bioglass®-based scaffolds: processing and characterization, J Biomed Mater Res Part A, 77A, 445, 10.1002/jbm.a.30636
Bretcanu, 2007, Biodegradable polymer coated 45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering, Glass Technol – Eur J Glass Sci Technol Part A, 48, 227
Blaker, 2010, Premature degradation of poly(alpha-hydroxyesters) during thermal processing of Bioglass®-containing composites, Acta Biomater, 6, 756, 10.1016/j.actbio.2009.08.020
Eglin, 2009, Degradation of synthetic polymeric scaffolds for bone and cartilage tissue repairs, Soft Matter, 5, 938, 10.1039/b803718n
Maquet, 2003, Preparation, characterization, and in vitro degradation of bioresorbable and bioactive composites based on Bioglass®-filled polylactide foams, J Biomed Mater Res Part A, 66A, 335, 10.1002/jbm.a.10587
Misra, 2010, Effect of nanoparticulate bioactive glass particles on bioactivity and cytocompatibility of poly(3-hydroxybutyrate) composites, J R Soc Interf, 7, 453, 10.1098/rsif.2009.0255
Fantner, 2006, Hierarchical interconnections in the nano-composite material bone: fibrillar cross-links resist fracture on several length scales, Compos Sci Technol, 66, 1205, 10.1016/j.compscitech.2005.10.005
Hunter, 1994, Modulation of crystal-formation by bone phosphoproteins – role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein, Biochem J, 302, 175, 10.1042/bj3020175
Marelli, 2011, Accelerated mineralization of dense collagen-nano bioactive glass hybrid gels increases scaffold stiffness and regulates osteoblastic function, Biomaterials, 32, 8915, 10.1016/j.biomaterials.2011.08.016
Bruggeman, 2008, Biodegradable poly(polyol sebacate) polymers, Biomaterials, 29, 4726, 10.1016/j.biomaterials.2008.08.037
Liang, 2012, Physical characterization of poly(glycerol sebacate)/Bioglass® composites, Polymer Int, 61, 17, 10.1002/pi.3165
Liang, 2008, Hypoxia inducible factor-1alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma, Anticancer Res, 28, 1659
Novak, 1993, Hybrid nanocomposite materials – between inorganic glasses and organic polymers, Adv Mater, 5, 422, 10.1002/adma.19930050603
Valliant, 2011, Softening bioactive glass for bone regeneration: sol–gel hybrid materials, Soft Matter, 7, 5083, 10.1039/c0sm01348j
Mahony, 2010, Silica-gelatin hybrids with tailorable degradation and mechanical properties for tissue regeneration, Adv Funct Mater, 20, 3835, 10.1002/adfm.201000838
Jones, 2009, New trends in bioactive scaffolds: the importance of nanostructure, J Eur Ceram Soc, 29, 1275, 10.1016/j.jeurceramsoc.2008.08.003
Iler, 1979
Allo, 2010, Synthesis and electrospinning of epsilon-polycaprolactone-bioactive glass hybrid biomaterials via a sol–gel process, Langmuir, 26, 18340, 10.1021/la102845k
Pereira, 2005, Preparation of bioactive glass-polyvinyl alcohol hybrid foams by the sol–gel method, J Mater Sci – Mater Med, 16, 1045, 10.1007/s10856-005-4758-8
Gomide VS, Zonari A, Ocarino NM, Goes AM, Serakides R, Pereira MM. In vitro and in vivo osteogenic potential of bioactive glass-PVA hybrid scaffolds colonized by mesenchymal stem cells. Biomed Mater 2012;7. http://dx.doi.org/10.1088/1748-6041/7/1/015004.
Tsuru, 2001, Synthesis and in vitro behavior of organically modified silicate containing Ca ions, J Sol–Gel Sci Technol, 21, 89, 10.1023/A:1011217818285
Tsuru, 2004, Synthesis of bioactive and porous organic–inorganic hybrids for biomedical applications, J Sol–Gel Sci Technol, 32, 201, 10.1007/s10971-004-5789-1
Yabuta, 2003, Synthesis of PDMS-based porous materials for biomedical applications, J Sol–Gel Sci Technol, 26, 1219, 10.1023/A:1020772521781
Ren, 2002, Novel approach to fabricate porous gelatin-siloxane hybrids for bone tissue engineering, Biomaterials, 23, 4765, 10.1016/S0142-9612(02)00226-0
Rhee, 2002, Preparation of a bioactive and degradable poly(epsilon-caprolactone)/silica hybrid through a sol–gel method, Biomaterials, 23, 4915, 10.1016/S0142-9612(02)00251-X
Rhee, 2004, Evaluation of a novel poly(epsilon-caprolactone)-organosiloxane hybrid material for the potential application as a bioactive and degradable bone substitute, Biomacromolecules, 5, 1575, 10.1021/bm049885n
O’Brien, 2004, Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds, Biomaterials, 25, 1077, 10.1016/S0142-9612(03)00630-6
Richard, 2001, Poly(glutamic acid) for biomedical applications, Crit Rev Biotechnol, 21, 219, 10.1080/07388550108984171
Shih, 2001, Production of a biopolymer flocculant from Bacillus licheniformis and its flocculation properties, Bioresour Technol, 78, 267, 10.1016/S0960-8524(01)00027-X
Poologasundarampillai, 2010, Synthesis of bioactive class II poly(gamma-glutamic acid)/silica hybrids for bone regeneration, J Mater Chem, 20, 8952, 10.1039/c0jm00930j
Poologasundarampillai, 2012, Bioactive silica–poly(γ-glutamic acid) hybrids for bone regeneration: effect of covalent coupling on dissolution and mechanical properties and fabrication of porous scaffolds, Soft Matter, 8, 4822, 10.1039/c2sm00033d
Yang, 2010, Preparation and characterization of a novel chitosan scaffold, Carbohydr Polym, 80, 860, 10.1016/j.carbpol.2009.12.044
Shirosaki, 2009, Physical, chemical and in vitro biological profile of chitosan hybrid membrane as a function of organosiloxane concentration, Acta Biomater, 5, 346, 10.1016/j.actbio.2008.07.022
Shirosaki, 2005, In vitro cytocompatibility of MG63 cells on chitosan-organosiloxane hybrid membranes, Biomaterials, 26, 485, 10.1016/j.biomaterials.2004.02.056
Shirosaki, 2008, Synthesis and cytocompatibility of porous chitosan-silicate hybrids for tissue engineering scaffold application, Chem Eng J, 137, 122, 10.1016/j.cej.2007.10.012
Pereira, 2005, Bioactive glass and hybrid scaffolds prepared by sol–gel method for bone tissue engineering, Adv Appl Ceram, 104, 35, 10.1179/174367605225011034
Pereira, 1994, Calcium-phosphate formation on sol–gel-derived bioactive glasses in-vitro, J Biomed Mater Res, 28, 693, 10.1002/jbm.820280606
Ramila, 2002, Synthesis routes for bioactive sol–gel glasses: alkoxides versus nitrates, Chem Mater, 14, 542, 10.1021/cm0110876
Poologasundarampillai, 2011, Electrospun silica/PLLA hybrid materials for skeletal regeneration, Soft Matter, 7, 10241, 10.1039/c1sm06171b
Vallet-Regi, 2006, From the bioactive glasses to the star gels, J Mater Sci – Mater Med, 17, 1011, 10.1007/s10856-006-0437-7
Ashley, 2011, The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers, Nat Mater, 10, 389, 10.1038/nmat2992
Brunner TJ, Grass RN, Stark WJ. Glass and bioglass nanopowders by flame synthesis. Chem Commun 2006;13;1384–86.
Mohn, 2010, Radio-opaque nanosized bioactive glass for potential root canal application: evaluation of radiopacity, bioactivity and alkaline capacity, Int Endodont J, 43, 210, 10.1111/j.1365-2591.2009.01660.x
Vallet-Regi, 2007, Mesoporous materials for drug delivery, Angew Chem – Int Ed, 46, 7548, 10.1002/anie.200604488
Hong, 2010, Mono-dispersed bioactive glass nanospheres: preparation and effects on biomechanics of mammalian cells, J Biomed Mater Res Part A, 95A, 747, 10.1002/jbm.a.32898
Luz, 2011, Preparation and characterization of bioactive glass nanoparticles prepared by sol–gel for biomedical applications, Nanotechnology, 22, 494014, 10.1088/0957-4484/22/49/494014
Curtis, 2010, Synthesis of nanobioglass and formation of apatite rods to occlude exposed dentine tubules and eliminate hypersensitivity, Acta Biomater, 6, 3740, 10.1016/j.actbio.2010.02.045
Roohani-Esfahani, 2011, Effects of bioactive glass nanoparticles on the mechanical and biological behavior of composite coated scaffolds, Acta Biomater, 7, 1307, 10.1016/j.actbio.2010.10.015
Doostmohammadi, 2011, Bioactive glass nanoparticles with negative zeta potential, Ceram Int, 37, 2311, 10.1016/j.ceramint.2011.03.026
Yun, 2010, Synthesis of high surface area mesoporous bioactive glass nanospheres, Mater Lett, 64, 1850, 10.1016/j.matlet.2010.04.053
Ostomel, 2006, Spherical bioactive glass with enhanced rates of hydroxyapatite deposition and hemostatic activity, Small, 2, 1261, 10.1002/smll.200600177
Pirhonen, 2006, Manufacturing, mechanical characterization, and in vitro performance of bioactive glass 13–93 fibers, J Biomed Mater Res Part B, 77B, 227, 10.1002/jbm.b.30429
Stevens, 2005, Exploring and engineering the cell surface interface, Science, 310, 1135, 10.1126/science.1106587
Doshi, 1995, Electrospinning process applications of electrospun fibers, J Electrostat, 35, 151, 10.1016/0304-3886(95)00041-8
Reneker, 1996, Nanometre diameter fibres of polymer, produced by electrospinning, Nanotechnology, 7, 216, 10.1088/0957-4484/7/3/009
Lu, 2009, Electrospun submicron bioactive glass fibers for bone tissue scaffold, J Mater Sci – Mater Med, 20, 793, 10.1007/s10856-008-3649-1
Hong, 2010, Fabrication and drug delivery of ultrathin mesoporous bioactive glass hollow fibers, Adv Funct Mater, 20, 1501, 10.1002/adfm.200901627
Lee, 2010, Nanostructured poly(epsilon-caprolactone)-silica xerogel fibrous membrane for guided bone regeneration, Acta Biomater, 6, 3557, 10.1016/j.actbio.2010.03.022
Kim, 2010, Effects of poly(lactic-co-glycolic acid) (PLGA) degradability on the apatite-forming capacity of electrospun PLGA/SiO2-CaO nonwoven composite fabrics, J Biomed Mater Res Part B, 93B, 218, 10.1002/jbm.b.31578
Lovett, 2009, Vascularization strategies for tissue engineering, Tissue Eng Part B, 15, 353, 10.1089/ten.teb.2009.0085
Gorustovich, 2010, Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences, Tissue Eng Part B, 16, 199, 10.1089/ten.teb.2009.0416
Grunewald, 2006, VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells, Cell, 124, 175, 10.1016/j.cell.2005.10.036
Day, 2004, Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds, Biomaterials, 25, 5857, 10.1016/j.biomaterials.2004.01.043
Day, 2005, Bioactive glass stimulates the secretion of angiogenic growth factors and angiogenesis in vitro, Tissue Eng, 11, 768, 10.1089/ten.2005.11.768
Keshaw, 2005, Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass, Biomaterials, 26, 4171, 10.1016/j.biomaterials.2004.10.021
Leach, 2006, Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration, Biomaterials, 27, 3249, 10.1016/j.biomaterials.2006.01.033
Leu, 2008, Proangiogenic potential of a collagen/bioactive glass substrate, Pharmaceutical Res, 25, 1222, 10.1007/s11095-007-9508-9
Aguirre, 2010, Extracellular calcium modulates in vitro bone marrow-derived Flk-1(+) CD34(+) progenitor cell chemotaxis and differentiation through a calcium-sensing receptor, Biochem Biophys Res Commun, 393, 156, 10.1016/j.bbrc.2010.01.109
Gerhardt, 2011, The pro-angiogenic properties of multi-functional bioactive glass composite scaffolds, Biomaterials, 32, 4096, 10.1016/j.biomaterials.2011.02.032
Leu, 2009, Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect, Tissue Eng Part A, 15, 877, 10.1089/ten.tea.2008.0018
Day, 2005, In vitro and in vivo analysis of macroporous biodegradable poly(d,l-lactide-co-glycolide) scaffolds containing bioactive glass, J Biomed Mater Res Part A, 75A, 778, 10.1002/jbm.a.30433
Choi, 2006, Effect of synthetic bone glass particulate on the fibrovascularization of porous polyethylene orbital implants, Ophthalmic Plastic Recon Surg, 22, 121, 10.1097/01.iop.0000197022.19166.dd
Peters, 2005, Paradoxical effects of hypoxia-mimicking divalent cobalt ions in human endothelial cells in vitro, Mol Cell Biochem, 270, 157, 10.1007/s11010-005-4504-z
Azevedo, 2010, Synthesis and characterization of hypoxia-mimicking bioactive glasses for skeletal regeneration, J Mater Chem, 20, 8854, 10.1039/c0jm01111h
Wu, 2012, Hypoxia-mimicking mesoporous bioactive glass scaffolds with controllable cobalt ion release for bone tissue engineering, Biomaterials, 33, 2076, 10.1016/j.biomaterials.2011.11.042
Stoor, 1998, Antibacterial effects of a bioactive glass paste on oral microorganisms, Acta Odontol Scand, 56, 161, 10.1080/000163598422901
Munukka, 2008, Bactericidal effects of bioactive glasses on clinically important aerobic bacteria, J Mater Sci – Mater Med, 19, 27, 10.1007/s10856-007-3143-1
Zhang, 2010, Antibacterial effects and dissolution behavior of six bioactive glasses, J Biomed Mater Res Part A, 93A, 475, 10.1002/jbm.a.32564
Bellantone, 2000, Bacteriostatic action of a novel four-component bioactive glass, J Biomed Mater Res, 51, 484, 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
Bellantone, 2002, Broad-spectrum bactericidal activity of Ag2O-doped bioactive glass, Antimicrob Agents Chemother, 46, 1940, 10.1128/AAC.46.6.1940-1945.2002
El-Kady, 2012, Synthesis, characterization and microbiological response of silver doped bioactive glass nanoparticles, Ceram Int, 38, 177, 10.1016/j.ceramint.2011.05.158
Waltimo, 2007, Antimicrobial effect of nanometric bioactive glass 45S5, J Dent Res, 86, 754, 10.1177/154405910708600813
Ahmed, 2011, Preparation and characterization of antibacterial P2O5–CaO–Na2O–Ag2O glasses, J Biomed Mater Res Part A, 98A, 132, 10.1002/jbm.a.33101
Oki, 2004, Preparation and in vitro bioactivity of zinc containing sol–gel-derived bioglass materials, J Biomed Mater Res Part A, 69A, 216, 10.1002/jbm.a.20070
Boyd, 2009, Preliminary investigation of novel bone graft substitutes based on strontium-calcium-zinc-silicate glasses, J Mater Sci – Mater Med, 20, 413, 10.1007/s10856-008-3569-0
Saino, 2011, In vitro calcified matrix deposition by human osteoblasts onto a zinc-containing bioactive glass, Eur Cells Mater, 21, 59, 10.22203/eCM.v021a05
Oh, 2011, Effects on growth and osteogenic differentiation of mesenchymal stem cells by the zinc-added sol–gel bioactive glass granules, J Tissue Eng, 2010, 475260
Aina, 2007, Cytotoxicity of zinc-containing bioactive glasses in contact with human osteoblasts, Chem-Biol Interact, 167, 207, 10.1016/j.cbi.2007.03.002
Bonnelye, 2008, Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro, Bone, 42, 129, 10.1016/j.bone.2007.08.043
Gentleman, 2010, The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro, Biomaterials, 31, 3949, 10.1016/j.biomaterials.2010.01.121
Fredholm, 2012, Influence of strontium for calcium substitution in bioactive glasses on degradation, ion release and apatite formation, J R Soc Interf, 9, 880, 10.1098/rsif.2011.0387
Fredholm, 2010, Strontium containing bioactive glasses: glass structure and physical properties, J Non-Cryst Solids, 356, 2546, 10.1016/j.jnoncrysol.2010.06.078
Xiang, 2011, Effect of strontium substitution on the structure of 45S5 Bioglasses, Chem Mater, 23, 2703, 10.1021/cm102889q
Gorustovich AA, Steimetz T, Cabrini RL, Lopez JMP. Osteoconductivity of strontium-doped bioactive glass particles: a histomorphometric study in rats. J Biomed Mater Res Part A 2010;92A:232–37.
O’Donnell, 2010, Influence of strontium and the importance of glass chemistry and structure when designing bioactive glasses for bone regeneration, Acta Biomater, 6, 2382, 10.1016/j.actbio.2010.01.006
Lao, 2008, Strontium-delivering glasses with enhanced bioactivity: a new biomaterial for antiosteoporotic applications?, Chem Mater, 20, 4969, 10.1021/cm800993s
Hesaraki, 2010, The effect of Sr concentration on bioactivity and biocompatibility of sol–gel derived glasses based on CaO–SrO–SiO2–P2O5 quaternary system, Mater Sci Eng, C, 30, 383, 10.1016/j.msec.2009.12.001
Lao, 2009, New strontium-based bioactive glasses: physicochemical reactivity and delivering capability of biologically active dissolution products, J Mater Chem, 19, 2940, 10.1039/b822214b
Isaac, 2011, Effects of strontium-doped bioactive glass on the differentiation of cultured osteogenic cells, Eur Cells Mater, 21, 130, 10.22203/eCM.v021a11